InVivo Therapeutics (NVIV) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free NVIV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisEarningsHeadlinesShort InterestSocial MediaStock AnalysisEarningsHeadlinesShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGut health supplements are everywhere – but which are the best ones for *you*?msn.com - March 28 at 4:18 PMInVivo Therapeutics Holdings Corporationcnn.com - February 15 at 12:40 AMInVivo Therapeutics Holdings Corp.wsj.com - February 14 at 2:40 PMFirm Retention Summary: InVivo Therapeutics Holdingswsj.com - February 13 at 6:29 PMInVivo Therapeutics Holdings Corp (NVIV)investing.com - February 7 at 11:49 PMBob Langer-founded device-maker declares bankruptcybizjournals.com - February 6 at 4:38 PMmarketbeat.com - February 6 at 12:10 PMmarketbeat.com - February 6 at 11:47 AMWhy Is InVivo Therapeutics (NVIV) Stock Up 61% Today?investorplace.com - February 6 at 9:12 AMInVivo Therapeutics Shares Plumb New Depths After Bankruptcy Filingmarketwatch.com - February 1 at 2:09 PMmarketbeat.com - February 1 at 7:57 AMInVivo Therapeutics Holdings Corp NVIVmorningstar.com - November 10 at 7:26 AMSpinal Cord Trauma Treatment Market Analysis: Examining Trends and Forecasting Revenue Growth with an estimated CAGR 6.2% from 2023-2030marketwatch.com - June 22 at 5:14 PMRing Therapeutics Strengthens Executive Team with Appointment of Christopher McNulty as Chief Financial Officer, Head of Corporate Strategybenzinga.com - May 1 at 12:30 PMWhy InVivo Therapeutics Shares Are Plunging Todayfinance.yahoo.com - March 17 at 1:53 AMInVivo seeks longer-term control in Casino-Teract retail tie-upmsn.com - March 10 at 6:45 PMWhy Barnes & Noble Education Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarketmsn.com - March 10 at 6:45 PMU.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.66%msn.com - March 10 at 3:10 AMWhy JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionmsn.com - March 9 at 5:08 PMInVivo : INSPIRE 2.0 Study In Acute Spinal Cord Injury Fails To Meet Primary Endpointmarkets.businessinsider.com - March 9 at 5:08 PMInVivo to evaluate strategic options as trial for spinal injury device failsmsn.com - March 9 at 5:08 PMInVivo Therapeutics Shares Hit 52-Week Low After Study Misses Primary Endpointmarketwatch.com - March 9 at 5:08 PMInVivo Therapeutics Study for Neuro-Spinal Scaffold Misses Primary Endpointmarketwatch.com - March 9 at 9:54 AMInVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injuryfinance.yahoo.com - March 9 at 9:54 AMmarketbeat.com - March 9 at 8:51 AMInVivo Therapeutics Hldg Stock (NASDAQ:NVIV), Quotes and News Summarybenzinga.com - January 11 at 8:35 PMInVivo Therapeutics Announces Closing of $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - October 11 at 6:58 PMInVivo Therapeutics Shares Continue Friday's Fall, Hit All-Time Intraday Lowmarketwatch.com - October 10 at 1:53 PMInVivo Therapeutics dips 24% on $9M direct and private placement offeringsseekingalpha.com - October 7 at 1:56 PMInVivo Therapeutics Stock Drops on $9 Million Offeringmarketwatch.com - October 7 at 1:56 PMWhy Is InVivo Therapeutics (NVIV) Stock Down 34% Today?investorplace.com - October 7 at 11:00 AMInVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - October 7 at 8:55 AMmarketbeat.com - October 6 at 3:47 PMInVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 9 at 8:12 AMInVivo Therapeutics Holdings Corp. (NVIV)uk.finance.yahoo.com - August 28 at 8:41 PMmarketbeat.com - August 5 at 9:49 AMmarketbeat.com - August 4 at 10:47 AMmarketbeat.com - August 4 at 10:18 AMmarketbeat.com - August 4 at 10:07 AMmarketbeat.com - August 4 at 9:57 AMmarketbeat.com - August 4 at 9:44 AMInVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counselfinance.yahoo.com - July 13 at 9:32 AMInVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgeryfinance.yahoo.com - June 8 at 9:06 AMInVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Studyfinance.yahoo.com - June 2 at 11:49 AMWhy Are InVivo Therapeutics Shares Trading Lower During Premarket Monday?finance.yahoo.com - April 18 at 12:59 PMWhy InVivo Therapeutics Stock Falling?nasdaq.com - April 15 at 8:14 AMInVivo Therapeutics Announces 1-for-25 Reverse Stock Splitmarketwatch.com - April 14 at 10:13 PMInVivo Therapeutics stock sinks after 1-for-25 reverse stock split announcedfinance.yahoo.com - April 14 at 10:13 PMInVivo Therapeutics slumps 7% on 1-for-25 reverse stock splitseekingalpha.com - April 14 at 5:12 PMSidekick Health: DTx leader Sidekick announces key C-level hires in move to accelerate U.S. market growthfinanznachrichten.de - February 8 at 10:34 AM Get InVivo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NVIV and its competitors with MarketBeat's FREE daily newsletter. Email Address At first glance, this chart looks like nonsense… (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates” But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… NVIV Media Mentions By Week NVIV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVIV News Sentiment▼0.790.44▲Average Medical News Sentiment NVIV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVIV Articles This Week▼00▲NVIV Articles Average Week Get InVivo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NVIV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SINT News BJDX News MOTS News INVO News NMRD News QNRX News DYNT News TNON News AEMD News VRAX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVIV) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InVivo Therapeutics Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
